Vol 61, No 1 (2010)
Original article
Published online: 2010-05-21
Varicella among seafarers: a case study on testing and vaccination as a cost-effective method of prevention
IMH 2010;61(1):32-35.
Abstract
Background. Many individuals together in semi-confined settings increase the risk of outbreaks of infectious
diseases. A single case of varicella on a cruise ship can thus result in rapid spread and elevated costs
for the cruise provider in terms of repatriation, ship diversion, law suits, and loss in current and potential
future revenue. Control of varicella involves attention to good personal hygiene, safe food and water handling,
and use of vaccine.
Objectives. To test crewmembers during their pre-employment medical examination to determine who might be susceptible to contract varicella if exposed, to vaccinate those at risk, and to see whether the benefits of testing and vaccination outweigh the costs.
Material and methods. Tests were conducted on 121 Indian seafarers for varicella IgG and IgM antibodies during their pre-employment medical examination in Mumbai and Goa from December 1st to December 23rd 2008. Cases without IgG antibodies to varicella (IgG negative) were administered vaccine.
Results. Twenty (16.5%) seafarers who tested IgG negative and one who tested equivocally were administered the vaccine. One hundred (82.7%) tested positive for IgG antibodies and were therefore not vaccinated. None tested positive for IgM antibodies, indicating no active infection.
Conclusions. One in six Indian seafarers tested IgG negative and was thus at risk to contract varicella if exposed. Testing for varicella IgG and IgM antibodies, followed by vaccination when necessary, is a costeffective method to prevent an expensive outbreak in the semi-confined setting of a cruise ship and is recommended as a mandatory part of the pre-employment medical examination for Indian seafarers.
Int Marit Health 2010; 61, 1: 32-35
Objectives. To test crewmembers during their pre-employment medical examination to determine who might be susceptible to contract varicella if exposed, to vaccinate those at risk, and to see whether the benefits of testing and vaccination outweigh the costs.
Material and methods. Tests were conducted on 121 Indian seafarers for varicella IgG and IgM antibodies during their pre-employment medical examination in Mumbai and Goa from December 1st to December 23rd 2008. Cases without IgG antibodies to varicella (IgG negative) were administered vaccine.
Results. Twenty (16.5%) seafarers who tested IgG negative and one who tested equivocally were administered the vaccine. One hundred (82.7%) tested positive for IgG antibodies and were therefore not vaccinated. None tested positive for IgM antibodies, indicating no active infection.
Conclusions. One in six Indian seafarers tested IgG negative and was thus at risk to contract varicella if exposed. Testing for varicella IgG and IgM antibodies, followed by vaccination when necessary, is a costeffective method to prevent an expensive outbreak in the semi-confined setting of a cruise ship and is recommended as a mandatory part of the pre-employment medical examination for Indian seafarers.
Int Marit Health 2010; 61, 1: 32-35
References
- Schultz MG. Emporiatrics--travellers' health. BMJ. 1982; 285(6342): 582–583.
- New Zealand Dermatological Society 14.01.2006.
- Varicella-Zoster-Virus IgM ELISA and VIDAS Varicella Zoster IgG testing literature. www.biomerieux.com.
- Varilrix Varicella Vaccine prescribing information. www.gsk.com.au.
- Buchholz U, Moolenaar R, Peterson C, et al. Varicella outbreaks after vaccine licensure: should they make you chicken? Pediatrics. 1999; 104(3 Pt 1): 561–563.
- Fine PE, Zell ER. Outbreaks in highly vaccinated populations: implications for studies of vaccine performance. Am J Epidemiol. 1994; 139(1): 77–90.
- Addiss DG, Yashuk JC, Clapp DE, et al. Outbreaks of diarrhoeal illness on passenger cruise ships, 1975-85. Epidemiol Infect. 1989; 103(1): 63–72.
- Christenson B, Lidin-Janson G, Kallings I. Outbreak of respiratory illness on board a ship cruising to ports in southern Europe and northern Africa. J Infect. 1987; 14(3): 247–254.
- Koo D, Maloney K, Tauxe R. Epidemiology of diarrheal disease outbreaks on cruise ships, 1986 through 1993. JAMA. 1996; 275(7): 545–547.
- Merson MH, Hughes JM, Wood BT, et al. Gastrointestinal illness on passenger cruise ships. JAMA. 1975; 231(7): 723–727.
- Lumish RM, Ryder RW, Anderson DC, et al. Heat-labile enterotoxigenic Escherichia coli induced diarrhea aboard a Miami-based cruise ship. Am J Epidemiol. 1980; 111(4): 432–436.
- O'Mahony M, Noah ND, Evans B, et al. An outbreak of gastroenteritis on a passenger cruise ship. J Hyg (Lond). 1986; 97(2): 229–236.
- Gunn RA, Terranova WA, Greenberg HB, et al. Norwalk virus gastroenteritis aboard a cruise ship: an outbreak on five consecutive cruises. Am J Epidemiol. 1980; 112(6): 820–827.
- Davies JW, Simon WR, Bowmer EJ, et al. Typhoid at sea: epidemic aboard an ocean liner. Can Med Assoc J. 1972; 106(8): 877–883.
- Merson MH, Tenney JH, Meyers JD, et al. Shigellosis at sea: an outbreak aboard a passenger cruise ship. Am J Epidemiol. 1975; 101(2): 165–175.
- Waterman SH, Demarcus TA, Wells JG, et al. Staphylococcal food poisoning on a cruise ship. Epidemiol Infect. 1987; 99(2): 349–353.
